9552042

Source:http://linkedlifedata.com/resource/pubmed/id/9552042

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:9552042	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0239307	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0008976	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0684249	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0043227	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0034656	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0008838	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0020823	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0079083	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0205390	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C1563350	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C0205179	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C1563351	lld:lifeskim
pubmed-article:9552042	lifeskim:mentions	umls-concept:C1518904	lld:lifeskim
pubmed-article:9552042	pubmed:issue	4	lld:pubmed
pubmed-article:9552042	pubmed:dateCreated	1998-5-12	lld:pubmed
pubmed-article:9552042	pubmed:abstractText	A phase III randomized trial in patients with advanced non-small-cell lung cancer (NSCLC) was performed to determine if the addition of ifosfamide to moderate-dose cisplatin and carboplatin improved response rate (primary end point) and survival.	lld:pubmed
pubmed-article:9552042	pubmed:language	eng	lld:pubmed
pubmed-article:9552042	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:9552042	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:9552042	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:9552042	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:9552042	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:9552042	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:9552042	pubmed:month	Apr	lld:pubmed
pubmed-article:9552042	pubmed:issn	0732-183X	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:KlasterskyJJ	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:LecomteJJ	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:AlexopoulosC...	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:LafitteJ JJJ	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:BureauGG	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:SculierJ PJP	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:PaesmansMM	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:BerchierM CMC	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:ThiriauxJJ	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:NinaneVV	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:ZachariaeMM	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:GinerVV	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:MommenPP	lld:pubmed
pubmed-article:9552042	pubmed:author	pubmed-author:EfremidisAA	lld:pubmed
pubmed-article:9552042	pubmed:issnType	Print	lld:pubmed
pubmed-article:9552042	pubmed:volume	16	lld:pubmed
pubmed-article:9552042	pubmed:owner	NLM	lld:pubmed
pubmed-article:9552042	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:9552042	pubmed:pagination	1388-96	lld:pubmed
pubmed-article:9552042	pubmed:dateRevised	2006-11-15	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:meshHeading	pubmed-meshheading:9552042-...	lld:pubmed
pubmed-article:9552042	pubmed:year	1998	lld:pubmed
pubmed-article:9552042	pubmed:articleTitle	Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.	lld:pubmed
pubmed-article:9552042	pubmed:affiliation	Institut Jules Bordet, Bruxelles, Belgium. 101473.1044@compuserve.com	lld:pubmed
pubmed-article:9552042	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:9552042	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:9552042	pubmed:publicationType	Comparative Study	lld:pubmed
pubmed-article:9552042	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:9552042	pubmed:publicationType	Multicenter Study	lld:pubmed
pubmed-article:9552042	pubmed:publicationType	Clinical Trial, Phase III	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:9552042	lld:pubmed